22 June 2005 Clinical trials in Russia: achieving excellence
Author Affiliations +
Abstract
The Russian population offers a unique opportunity for conducting clinical trials in general, and specifically in the area of Medical Devices. Although the regulatory framework for approval of clinical trials and eventual marketing registration is based on an American-style format, details of operating in the Russian framework are very different. Understanding and leveraging the unique characteristics of the Russian system on the patient side, the investigator side, and the regulatory side is important in extracting optimum value out of clinical trials in Russia. Having performed Medical Device research and clinical trials in Russia, the authors overview the present system and describe various strategies for working in this growing but still under-utilized clinical trials arena.
© (2005) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Robert S. Reznik, Robert S. Reznik, Thomas E. Ichim, Thomas E. Ichim, Vladimir Petrov, Vladimir Petrov, Boris N. Reznik, Boris N. Reznik, } "Clinical trials in Russia: achieving excellence", Proc. SPIE 5771, Saratov Fall Meeting 2004: Optical Technologies in Biophysics and Medicine VI, (22 June 2005); doi: 10.1117/12.634618; https://doi.org/10.1117/12.634618
PROCEEDINGS
6 PAGES


SHARE
RELATED CONTENT

Medical device clinical trial: design, conduct, and analysis
Proceedings of SPIE (December 05 1994)
Role of technology in device development
Proceedings of SPIE (October 26 1995)
Effect of the FDA on health care investments
Proceedings of SPIE (December 05 1994)
Ethics of technology introduction
Proceedings of SPIE (October 26 1995)
Problems caused by regulatory delays and regulation
Proceedings of SPIE (December 05 1994)

Back to Top